XML 40 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated statements of cash flows - USD ($)
12 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2019
Operating activities      
Net loss for the year $ (226,559,288) $ (9,275,962) $ (4,100,782)
Items not affecting cash      
Share-based compensation 3,982,943 332,634 97,258
Listing fee 152,719,009 0 0
Depreciation 2,899,350 1,095,250 183,862
Amortization of government grants (92,926) (2,226,910) (640,350)
Loss on disposal of assets 13,399 106,946 0
Foreign exchange (gain) loss on translation 677,479 (390,901) (33,845)
Fair value loss on financial instruments 38,254,469 84,454 0
Share-based professional fees 0 455,055 0
Interest and accretion on convertible debt 1,129,680 9,931 60,337
Cash flows from (used in) operations before changes in working capital (26,975,885) (9,809,503) (4,433,520)
Changes in non-cash working capital items      
Accounts receivable (3,501,401) (538,854) (29,630)
Other receivables (654,216) 471,304 (466,915)
Prepayments and deposits (7,990,108) (633,824) (215,537)
Inventory (1,017,813) (133,438) (46,556)
Accounts payable and accrued liabilities 12,262,063 3,215,386 624,090
Net cash provided by operating activities (27,877,360) (7,428,929) (4,568,068)
Investing activity      
Purchases of plant and equipment (18,220,339) (5,107,663) (998,069)
Proceeds from disposal of plant and equipment 16,866 0 0
Net cash used in investing activities (18,203,473) (5,107,663) (998,069)
Financing activities      
Proceeds from exercise of stock options 169,105 0 0
Proceeds from exercise of warrants 1,150
Proceeds from convertible debt 98,400,263 0 0
Proceeds from loans payable 10,091,220 2,153,110 86,572
Proceeds from government grants 92,926 1,182,599 1,697,794
Repayment of lease liabilities (884,024) (387,508) 0
Repayment of loans payable (12,544,339) (12,881) 0
Net cash used in financing activities 642,275,574 9,416,701 7,164,226
Net change in cash and cash equivalents 596,194,741 (3,119,891) 1,598,089
Cash and cash equivalents, beginning of period 663,557 3,783,449 2,185,360
Cash and cash equivalents, end of period 596,858,298 663,557 3,783,449
Non-cash investing activities      
Accrual for purchase of plant and equipment 2,074,681 0 0
Non cash purchase of plant and equipment 2,084,235 0 0
Non-cash financing activities      
Equity issued for non-cash costs 0 947,464 118,759
Private Shares      
Financing activities      
Proceeds from share issuance, net of share issuance costs 21,620,000 6,481,381 5,379,860
Public Shares      
Financing activities      
Proceeds from share issuance, net of share issuance costs $ 525,329,273 $ 0 $ 0